Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
Pushpinder Singh, Dialysis Technician at Fortis Healthcare, shared a post on LinkedIn:
How Do We Know if Haemodialysis is Effective?
Dialysis adequacy is assessed using different principles and measurements that help evaluate solute removal and the delivered dialysis dose.
1. How Does Dialysis Remove Waste?
- Diffusion: Solutes such as urea move from higher to lower concentration across the dialyzer membrane.
- Convection: Water moves across the membrane due to a pressure gradient, carrying some solutes with it. This is called solvent drag.
2. Important Measures of Dialysis Adequacy
- URR (Urea Reduction Ratio): Measures the percentage reduction in blood urea during dialysis.
- Kt/V: Measures the delivered dialysis dose relative to the patient’s urea distribution volume.
3. Types of Kt/V
- spKt/V: Single-Pool Kt/V.
- eKt/V: Equilibrated Kt/V, accounting for post-dialysis urea rebound.
- stdKt/V: Standard Kt/V, used to compare dialysis dose across different treatment schedules.
4. What Is Urea Rebound?
- After dialysis ends, blood urea may rise again as urea moves from body compartments with relatively higher urea concentration back into the bloodstream.
5. What Is Access Recirculation?
- It occurs when recently dialysed blood returns to the dialyzer inlet without adequately mixing with the systemic circulation. It can reduce effective dialysis delivery.
Key Learning
Understanding diffusion, convection, URR, Kt/V, urea rebound, and access recirculation helps dialysis professionals understand the principles of dialysis adequacy.
Knowledge Check:
Which measurements are commonly used to assess dialysis adequacy?
A. URR
B. Kt/V
C. Both A and B
D. None of the above”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 11:09Neel Patel: Hematocon 2026 – Advancing Hematology Through Knowledge, Collaboration and Innovation
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA
-
Nov 20, 2026, 06:44Ann Van De Velde: Emerging Advances in Hemoglobinopathies, Sickle Cell Disease and Rare Anemias
-
Nov 20, 2026, 06:29Markus Müller: ABO Blood Groups and the Rare Bombay Phenotype
-
Nov 20, 2026, 05:57Lance Reed: Specialized Blood Components and Clinical Samples for Research and Diagnostics
-
Nov 20, 2026, 05:41Sundas Anjum: Community Engagement and Blood Donation for Thalassemia Care
-
Nov 20, 2026, 05:24A Celebration of Unity and Dedication in Hemophilia Care – Hemophilia Society Mumbai Chapter
-
Nov 20, 2026, 05:09Farhad Sheikh: Prasugrel vs Ticagrelor in Acute Coronary Syndromes